Spotlight on Young MS Researchers

Rehabilitation is more than exercise – it is a personalised process of learning and adaptation that empowers people living with MS to maximise independence, participation and quality of life. In this episode – recorded at ECTRIMS 2025 in Barcelona during the joint ECTRIMS–RIMS me ...  Show more

Clinical trial results unveiled today at ACTRIMS Forum 2026 suggest that fenebrutinib may be a novel and effective treatment option for people living with primary progressive multiple sclerosis. In this exclusive episode providing the first expert discussion of the complete datas ...  Show more

Today I am speaking with Dr. Jin-Xiong She about all thing NAD+, we discuss what it is, how to measure your NAD+ levels, what impact your NAD+ levels have on your health and longevity, how to optimize your NAD+ levels and so much more!

<a href="https://www. ...

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds." He is now the co-founder, ...  Show more

The latest guidelines on disease-modifying treatment in multiple sclerosis (MS) from the Association of British Neurologists is discussed in this intercontinental podcast with perspectives from the UK, the USA, and Australia.   Participants: <ul> <li>Professor Alasdair Coles is H ...  Show more

#Artifical Intelligence The Innovation Village at Euroanaesthesia 2025 hosted a series of riveting discussions about the fast-evolving technologies and practices in the fields of Anaesthesiology and Intensive Care. Once again, it was a meeting space for healthcare professionals, ...  Show more